CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT - USD ($) $ in Thousands	Total	Previously Reported	Revision of Prior Period, Adjustment	Common	Common Previously Reported	Common Revision of Prior Period, Adjustment	Additional Paid-In Capital	Additional Paid-In Capital Previously Reported	Additional Paid-In Capital Revision of Prior Period, Adjustment	Accumulated Deficit	Accumulated Deficit Previously Reported
Increase (Decrease) in Temporary Equity [Roll Forward]
Temporary equity, ending balance	$ 325,201	$ 325,201
Temporary equity, beginning balance (in shares) at Dec. 31, 2020	40,255,926	42,383,516	(2,127,590)
Temporary equity, beginning balance at Dec. 31, 2020	$ 325,201	$ 325,201
Temporary equity, ending balance (in shares) at Mar. 31, 2021	40,255,926
Beginning balance (in shares) at Dec. 31, 2020				9,392,361	9,888,776	(496,415)
Beginning balance at Dec. 31, 2020	$ (308,442)	$ (308,442)		$ 1	$ 0	$ 1	$ 6,982	$ 6,983	$ (1)	$ (315,425)	$ (315,425)
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]
Stock-based compensation	375						375
Exercises of common stock options (in shares)				38,430
Exercises of common stock options	68						68
Retroactive application of recapitalization (in shares)				(1,904)
Series C-3 preferred stock remeasurement	401						401
Net loss	(14,205)									(14,205)
Ending balance (in shares) at Mar. 31, 2021				9,428,887
Ending balance at Mar. 31, 2021	(322,605)			$ 1			7,024			(329,630)
Increase (Decrease) in Temporary Equity [Roll Forward]
Temporary equity, ending balance	325,602
Temporary equity, ending balance	$ 0
Temporary equity, beginning balance (in shares) at Dec. 31, 2021	0
Temporary equity, beginning balance at Dec. 31, 2021	$ 0
Temporary equity, ending balance (in shares) at Mar. 31, 2022	0
Beginning balance (in shares) at Dec. 31, 2021				66,647,242
Beginning balance at Dec. 31, 2021	$ (1,575)			$ 7			383,066			(384,648)
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]
Stock-based compensation	$ 5,180						5,180
Exercises of common stock options (in shares)	0
Exercise of warrants (in shares)				821
Exercise of warrants	$ 11						11
Issuance of awards related to acquisition (in shares)				267,141
Issuance of awards related to acquisition	3,000						3,000
Net loss	(36,211)									(36,211)
Ending balance (in shares) at Mar. 31, 2022				66,915,204
Ending balance at Mar. 31, 2022	(29,595)			$ 7			$ 391,257			$ (420,859)
Increase (Decrease) in Temporary Equity [Roll Forward]
Temporary equity, ending balance	$ 0